STOCK TITAN

[Form 4] GE HealthCare Technologies Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Holton Adam Y, identified as an officer (Chief People Officer) of GE HealthCare Technologies Inc. (GEHC), reported a transaction dated 09/01/2025. The filing shows 464 shares of GEHC common stock were disposed of at a price of $73.73 per share under transaction code F. The report states these shares were withheld to satisfy tax withholding obligations related to the vesting of restricted stock units. After the withholding, the reporting person beneficially owned 16,768 shares. The Form 4 was signed by an attorney-in-fact, Frank R. Jimenez, on 09/03/2025.

Holton Adam Y, indicato come dirigente (Chief People Officer) di GE HealthCare Technologies Inc. (GEHC), ha comunicato una transazione datata 01/09/2025. La dichiarazione riporta che 464 azioni ordinarie GEHC sono state cedute al prezzo di $73,73 ciascuna con il codice di transazione F. Il documento specifica che queste azioni sono state trattenute per adempiere a obblighi di ritenuta fiscale connessi al vesting di unità azionarie vincolate. Dopo la trattenuta, la persona segnalante deteneva beneficiariamente 16.768 azioni. Il Modulo 4 è stato firmato per procura dall'avvocato Frank R. Jimenez in data 03/09/2025.

Holton Adam Y, identificado como ejecutivo (Chief People Officer) de GE HealthCare Technologies Inc. (GEHC), reportó una transacción con fecha 01/09/2025. El informe indica que se dispusieron 464 acciones ordinarias de GEHC a un precio de $73.73 por acción bajo el código de transacción F. Se señala que estas acciones fueron retenidas para cumplir con las obligaciones de retención fiscal derivadas del vesting de unidades accionariales restringidas. Tras la retención, la persona informante poseía beneficiariamente 16,768 acciones. El Formulario 4 fue firmado por apoderado, Frank R. Jimenez, el 03/09/2025.

Holton Adam Y는 GE HealthCare Technologies Inc.(GEHC)의 임원(Chief People Officer)으로 표시되어 있으며, 2025-09-01자 거래를 보고했습니다. 신고서에 따르면 464주의 GEHC 보통주가 거래 코드 F로 주당 $73.73에 처분되었습니다. 해당 주식은 제한주식 단위의 베스팅과 관련된 세금 원천징수 의무를 충당하기 위해 원천징수되었다고 명시되어 있습니다. 원천징수 후 보고인은 16,768주를 실질적으로 보유하게 되었습니다. Form 4는 2025년 09/03에 법정대리인 Frank R. Jimenez가 서명했습니다.

Holton Adam Y, identifié comme dirigeant (Chief People Officer) de GE HealthCare Technologies Inc. (GEHC), a déclaré une transaction datée du 01/09/2025. Le dépôt indique que 464 actions ordinaires GEHC ont été cédées au prix de 73,73 $ par action sous le code de transaction F. Le rapport précise que ces actions ont été retenues pour satisfaire des obligations de retenue fiscale liées au vesting d'unités d'actions restreintes. Après cette retenue, la personne déclarante détenait à titre bénéficiaire 16 768 actions. Le formulaire 4 a été signé par un mandataire, Frank R. Jimenez, le 03/09/2025.

Holton Adam Y, ausgewiesen als leitender Angestellter (Chief People Officer) von GE HealthCare Technologies Inc. (GEHC), meldete eine Transaktion vom 01.09.2025. Die Einreichung zeigt, dass 464 Aktien der GEHC-Stammaktien zu einem Preis von $73,73 pro Aktie unter dem Transaktionscode F veräußert wurden. Im Bericht wird angegeben, dass diese Aktien einbehalten wurden, um steuerliche Abzugsverpflichtungen im Zusammenhang mit dem Vesting eingeschränkter Aktieneinheiten zu erfüllen. Nach dem Einbehalt besaß die meldende Person wirtschaftlich 16.768 Aktien. Das Formular 4 wurde am 03.09.2025 von einem Bevollmächtigten, Frank R. Jimenez, unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine tax-withholding sale of vested restricted stock units; no indication of trading for investment purposes.

The filing documents a standard withholding of 464 shares to satisfy tax obligations from RSU vesting at $73.73 per share, leaving the reporting person with 16,768 shares. This type of transaction is commonly used to cover tax liabilities and is recorded under transaction code F. There is no disclosure of additional sales or purchases that would suggest active trading or a change in insider view of company prospects. The filing was executed by counsel as attorney-in-fact, which is typical for administrative processing of equity compensation.

TL;DR: Administrative equity withholding tied to compensation vesting; governance controls appear to be followed.

The Form 4 indicates the company processed a share withholding to cover taxes on vested RSUs for an officer, which is a routine compensation administration event. The filing identifies the reporter92s role as Chief People Officer and includes the post-transaction beneficial ownership of 16,768 shares. Signature by the General Counsel as attorney-in-fact is consistent with delegated filing authority. There are no governance red flags such as unexplained transfers, related-party transactions, or large disposals reported here.

Holton Adam Y, indicato come dirigente (Chief People Officer) di GE HealthCare Technologies Inc. (GEHC), ha comunicato una transazione datata 01/09/2025. La dichiarazione riporta che 464 azioni ordinarie GEHC sono state cedute al prezzo di $73,73 ciascuna con il codice di transazione F. Il documento specifica che queste azioni sono state trattenute per adempiere a obblighi di ritenuta fiscale connessi al vesting di unità azionarie vincolate. Dopo la trattenuta, la persona segnalante deteneva beneficiariamente 16.768 azioni. Il Modulo 4 è stato firmato per procura dall'avvocato Frank R. Jimenez in data 03/09/2025.

Holton Adam Y, identificado como ejecutivo (Chief People Officer) de GE HealthCare Technologies Inc. (GEHC), reportó una transacción con fecha 01/09/2025. El informe indica que se dispusieron 464 acciones ordinarias de GEHC a un precio de $73.73 por acción bajo el código de transacción F. Se señala que estas acciones fueron retenidas para cumplir con las obligaciones de retención fiscal derivadas del vesting de unidades accionariales restringidas. Tras la retención, la persona informante poseía beneficiariamente 16,768 acciones. El Formulario 4 fue firmado por apoderado, Frank R. Jimenez, el 03/09/2025.

Holton Adam Y는 GE HealthCare Technologies Inc.(GEHC)의 임원(Chief People Officer)으로 표시되어 있으며, 2025-09-01자 거래를 보고했습니다. 신고서에 따르면 464주의 GEHC 보통주가 거래 코드 F로 주당 $73.73에 처분되었습니다. 해당 주식은 제한주식 단위의 베스팅과 관련된 세금 원천징수 의무를 충당하기 위해 원천징수되었다고 명시되어 있습니다. 원천징수 후 보고인은 16,768주를 실질적으로 보유하게 되었습니다. Form 4는 2025년 09/03에 법정대리인 Frank R. Jimenez가 서명했습니다.

Holton Adam Y, identifié comme dirigeant (Chief People Officer) de GE HealthCare Technologies Inc. (GEHC), a déclaré une transaction datée du 01/09/2025. Le dépôt indique que 464 actions ordinaires GEHC ont été cédées au prix de 73,73 $ par action sous le code de transaction F. Le rapport précise que ces actions ont été retenues pour satisfaire des obligations de retenue fiscale liées au vesting d'unités d'actions restreintes. Après cette retenue, la personne déclarante détenait à titre bénéficiaire 16 768 actions. Le formulaire 4 a été signé par un mandataire, Frank R. Jimenez, le 03/09/2025.

Holton Adam Y, ausgewiesen als leitender Angestellter (Chief People Officer) von GE HealthCare Technologies Inc. (GEHC), meldete eine Transaktion vom 01.09.2025. Die Einreichung zeigt, dass 464 Aktien der GEHC-Stammaktien zu einem Preis von $73,73 pro Aktie unter dem Transaktionscode F veräußert wurden. Im Bericht wird angegeben, dass diese Aktien einbehalten wurden, um steuerliche Abzugsverpflichtungen im Zusammenhang mit dem Vesting eingeschränkter Aktieneinheiten zu erfüllen. Nach dem Einbehalt besaß die meldende Person wirtschaftlich 16.768 Aktien. Das Formular 4 wurde am 03.09.2025 von einem Bevollmächtigten, Frank R. Jimenez, unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Holton Adam Y

(Last) (First) (Middle)
500 W. MONROE STREET

(Street)
CHICAGO IL 60661

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief People Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 09/01/2025 F 464(1) D $73.73 16,768 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Remarks:
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Holton Adam Y report on Form 4 for GEHC?

The report discloses a disposition of 464 shares of GEHC common stock on 09/01/2025 at $73.73 per share.

Why were the 464 shares disposed of according to the filing?

The filing states the shares were withheld to satisfy tax withholding obligations in connection with vested restricted stock units.

How many GEHC shares does the reporting person own after the transaction?

After the withholding, the reporting person beneficially owned 16,768 shares of GEHC common stock.

Who signed the Form 4 and when?

The Form 4 was signed by Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact on 09/03/2025.

What does transaction code 'F' indicate on this Form 4?

In this filing, transaction code F corresponds to the withholding/disposition of shares to satisfy tax obligations tied to vested equity awards, as explained in the form92s explanation section.
Ge Healthcare Technologies Inc

NASDAQ:GEHC

GEHC Rankings

GEHC Latest News

GEHC Latest SEC Filings

GEHC Stock Data

33.84B
455.24M
0.28%
87.11%
1.98%
Health Information Services
X-ray Apparatus & Tubes & Related Irradiation Apparatus
Link
United States
CHICAGO